ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,563Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 262

$455K Total Retail Price of All Prescriptions

Rank: 31 out of 262

460 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 460 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 460 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,596 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SIMVASTATIN 491 474 1 1
FUROSEMIDE 478 450 2 4
POTASSIUM CHLORIDE 399 353 3 10
LISINOPRIL 361 330 4 3
LEVOTHYROXINE SODIUM 361 341 4 2
AMLODIPINE BESYLATE 296 278 6 6
METOPROLOL SUCCINATE 255 223 7 11
OMEPRAZOLE 230 199 8 5
METFORMIN HCL 223 199 9 9
SERTRALINE HCL 221 208 10 14
WARFARIN SODIUM 212 212 11 12
ATENOLOL 209 206 12 16
HYDROCHLOROTHIAZIDE 200 195 13 7
METOPROLOL TARTRATE 193 193 14 8
LOSARTAN POTASSIUM 157 145 15 17
ATORVASTATIN CALCIUM 155 149 16 13
DIGOXIN 148 146 17 28
ISOSORBIDE MONONITRATE ER 146 146 18 33
HYDROCODONE-ACETAMINOPHEN 143 92 S3 19 15
TRAMADOL HCL 126 93 20 18
GLIMEPIRIDE 113 101 21 45
ADVAIR DISKUS 102 89 22 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 94 23 24
PRAVASTATIN SODIUM 90 89 24 41
DILTIAZEM ER 82 82 25 75
KLOR-CON M20 81 81 26 98
GABAPENTIN 77 63 27 19
TRAZODONE HCL 77 32 27 36
ALLOPURINOL 76 65 29 22
PEN NEEDLE 74 51 30 108
ALENDRONATE SODIUM 74 64 30 21
LANTUS SOLOSTAR 73 59 32 49
CYMBALTA 72 72 33 67
FAMOTIDINE 72 72 33 65
SPIRONOLACTONE 70 66 35 58
ZOLPIDEM TARTRATE 69 58 36 26
VENTOLIN HFA 62 48 37 142
RAMIPRIL 59 59 38 78
CARVEDILOL 58 56 39 31
JANTOVEN 57 57 40 39
TRIAMTERENE-HCTZ 55 54 41 32
KLOR-CON 10 53 53 42 72
PROAIR HFA 53 50 42 53
CRESTOR 52 52 44 30
CITALOPRAM HBR 52 50 44 20
TAMSULOSIN HCL 51 51 46 25
HUMALOG 51 50 46 100
FELODIPINE ER 51 51 46 127
DONEPEZIL HCL 50 50 49 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.